| SOXS 1.8066 0.93% | TPET 1.13 169.05% | ONDS 10.67 5.85% | NVDA 182.65 3.08% | STAK 0.7343 72.78% | TMDE 2.51 172.18% | BITO 9.4901 4.75% | TURB 1.24 83.59% | XLE 56.945 1.83% | DUST 3.635 2.68% | TZA 6.055 -2.81% | NOK 8.335 7.97% | NVD 7.07 -6.11% | RYDE 0.3315 43.26% | EONR 0.495 14.58% | BHAT 0.038 -23.23% | IBIT 39.03 4.95% | F 13.325 -5.43% | TQQQ 50.02 1.01% | SLV 80.98 -4.72% | MSTX 2.495 10.89% | PLUG 1.8083 1.02% | USEG 1.16 8.41% | TSLS 5.63 -0.18% | SOXL 62.305 -0.74% | AAL 12.505 -4.32% | AES 14.3188 -17.14% | JDST 1.2001 3.46% | BATL 11.73 112.50% | PLTR 146.0701 6.47% | HYG 80.375 -0.43% | NFLX 97.3 1.10% | QQQ 609.43 0.35% | SPY 687.9525 0.29% | SQQQ 70.125 -1.02% | MARA 9.61 7.49% | SOFI 18.135 2.11% | TSLL 14.705 0.03% | ETHA 15.37 5.85% | XLF 51.5345 0.20% | INTC 45.205 -0.89% | NU 15.309 2.20% | IWM 263.78 0.91% | TSLA 402.69 0.04% | TLT 89.4664 -1.49% | BMNR 20.43 7.64% | CRCG 3.0644 27.68% | NIO 4.7 -3.49% | BYND 0.8496 -10.15% | RIG 6.205 -4.24%

Calumet, Inc. (NASDAQ:CLMT) Sees Positive Analyst Sentiment Amidst Strategic Growth Initiatives

Calumet, Inc. (NASDAQ:CLMT) is a diversified manufacturer and marketer specializing in specialty branded products for consumer and industrial markets. The company operates through its segments: Specialty Products and Solutions, Montana/Renewables, and Performance Brands, offering a wide range of products such as solvents, lubricating oils, renewable fuels, and high-performance consumer products.

The stock consensus target price for Calumet has experienced fluctuations over the past year. Last month, the average price target was $20, reflecting optimism about the company's performance. This is an increase from the $16.63 target three months ago, indicating a positive shift in analyst sentiment. However, a year ago, the target was slightly higher at $20.42, showing some stability in the long-term outlook.

Calumet's recent performance in the renewable energy sector is noteworthy. Montana Renewables, a subsidiary, has achieved industry-leading breakeven costs and positive EBITDA, even in a challenging market. 

Financial performance also plays a crucial role in shaping analyst expectations. Despite reporting a net loss of $147.9 million in Q2 2025, Calumet achieved an adjusted EBITDA of $76.5 million. The company has been proactive in cost reduction, achieving $42 million in operating cost savings year-over-year, which may bolster confidence in its future prospects.

Calumet's strategic initiatives, such as the MaxSAF-150 project and securing a $782 million DOE loan, are expected to drive significant cash flow and margin expansion by 2026. These developments, along with strong performance in the Specialties segment, contribute to the overall positive outlook for the company, as reflected in the recent stock price increase of 12.5%.

Published on: November 7, 2025